![11 pediatric cardiovascular devices you need to know - Page 8 of 11 - Medical Design and Outsourcing 11 pediatric cardiovascular devices you need to know - Page 8 of 11 - Medical Design and Outsourcing](https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2018/09/EspeRareFlowatchmedium.jpg)
11 pediatric cardiovascular devices you need to know - Page 8 of 11 - Medical Design and Outsourcing
![Fundación EspeRare recibe el apoyo de Duchenne Parent Project España para iniciar en Barcelona el primer ensayo europeo en la seguridad clínica de Rimeporide en pacientes con distrofia muscular de Duchenne - Fundación EspeRare recibe el apoyo de Duchenne Parent Project España para iniciar en Barcelona el primer ensayo europeo en la seguridad clínica de Rimeporide en pacientes con distrofia muscular de Duchenne -](https://www.duchenne-spain.org/wp-content/uploads/2016/07/ID-duchenneesperare.jpg)
Fundación EspeRare recibe el apoyo de Duchenne Parent Project España para iniciar en Barcelona el primer ensayo europeo en la seguridad clínica de Rimeporide en pacientes con distrofia muscular de Duchenne -
![Caroline Kant email address & phone number | EspeRare foundation Co-Founder & CEO contact information - RocketReach Caroline Kant email address & phone number | EspeRare foundation Co-Founder & CEO contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/shiv-agarwal-2eaf914c.jpeg)
Caroline Kant email address & phone number | EspeRare foundation Co-Founder & CEO contact information - RocketReach
![Pierre Fabre and the EspeRare Foundation administer investigational treatment to first patient in EDELIFE clinical trial for rare genetic disease, XLHED Pierre Fabre and the EspeRare Foundation administer investigational treatment to first patient in EDELIFE clinical trial for rare genetic disease, XLHED](https://cloudfront-us-east-1.images.arcpublishing.com/gray/QD3SVWKHVEI4PR7XQWUZJ6VZEE.jpg)
Pierre Fabre and the EspeRare Foundation administer investigational treatment to first patient in EDELIFE clinical trial for rare genetic disease, XLHED
![Pierre Fabre on X: "The EspeRare Foundation and #PierreFabre join forces to develop and market a pioneering treatment for XLHED, a dermatological ultrarare genetic disease that requires prenatal therapeutic intervention. https://t.co/Kapqvu4RpT #Health # Pierre Fabre on X: "The EspeRare Foundation and #PierreFabre join forces to develop and market a pioneering treatment for XLHED, a dermatological ultrarare genetic disease that requires prenatal therapeutic intervention. https://t.co/Kapqvu4RpT #Health #](https://pbs.twimg.com/media/EpM4igPXMAIMdEi.jpg:large)